Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Dosage of Ropivacaine for Arthroscopic Knee Surgery

NCT04759742 is registered in ClinicalTrials.gov with Yanchao Yang as lead sponsor.

NCT NCT04759742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04759742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Dosage of Ropivacaine for Arthroscopic Knee Surgery
Lead sponsor
Yanchao Yang
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2021
Completion date
June 1, 2023
Enrollment
115 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthroscopic knee surgery, combined spinal epidurai anesthesia, ed50, ed95, ropivacaine